Kingsview Wealth Management, LLC Fulgent Genetics, Inc. Transaction History

Kingsview Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 17, 2022	SELL	$77.3 - $105.0 $258,568 - $351,225	-3,345 Closed	0 $0
Q3 2021 Dec 03, 2021	BUY	$74.87 - $110.87 $31,220 - $46,232	417 Added 14.24%	3,345 $301,000
Q2 2021 Aug 17, 2021	BUY	$66.8 - $100.45 $4,074 - $6,127	61 Added 2.13%	2,928 $256,000
Q1 2021 May 24, 2021	SELL	$59.3 - $183.85 $61,849 - $191,755	-1,043 Reduced 26.68%	2,867 $288,000
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $121,249 - $203,711	3,910 New	3,910 $204,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $541M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.